To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Electronic Travel Authorisations
Monday 22nd April 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Home Office:

To ask the Secretary of State for the Home Department, what plans he has to update the impact assessment for Electronic Travel Authorisation to include airside transit passengers.

Answered by Tom Pursglove

Electronic Travel Authorisations deliver important security benefits. A blanket exemption to the ETA requirement for passengers transiting airside would fundamentally undermine the rationale of the scheme by creating a permission free route of travel into the UK which would be open to abuse.

We will keep our position under review to monitor the impact on transit as the scheme is rolled out.


Written Question
Bowel Cancer: Screening
Monday 22nd April 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve genomics testing for bowel cancer patients.

Answered by Andrew Stephenson

A National Health Service testing programme is helping to diagnose thousands of people with a genetic condition, Lynch Syndrome, that increases the chance of developing certain cancers including bowel cancer. The national programme ensures all people diagnosed with bowel cancer are offered genomic testing, with a diagnosis for Lynch Syndrome not only helping to guide more personalised cancer treatment but enabling their families and relatives to be offered testing too. Relatives who receive a diagnosis of Lynch Syndrome can be referred to genetic services to discuss regular testing options to help catch any cancers as early as possible, as well as to consider preventive options such as taking aspirin or undergoing risk-reducing surgery.

Genomic testing in the NHS in England is provided through the NHS Genomic Medicine Service (GMS) and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory (NGTD) which outlines the full range of genomic testing offered by the NHS in England including tests for 3,200 rare diseases and over 200 cancer clinical indications, including both whole genome sequencing (WGS) and non-WGS testing. The NGTD sets out the eligibility criteria for patients to access testing as well as the genomic targets to be tested and the method that should be used, including testing for bowel cancer patients.

The NHS GMS cancer genomic testing strategy has facilitated a move to a consolidated laboratory network through the seven NHS GLHs delivering more extensive panel testing using cutting edge high throughput Next Generation Sequencing (NGS) technology. For patients, including those with bowel cancer, this technology enables testing for a larger number of genetic variations to give a more precise diagnosis, identify biomarkers to target treatment and opportunities to access innovative medicines, and can support enrolment into molecularly stratified clinical trials.

Testing is available for all eligible patients across the whole of England. Individuals should discuss with their healthcare professional (for example, their general practitioner or other healthcare professional if they are already being seen in a relevant service) whether genomic testing is appropriate for them. Their healthcare professional will then make a decision whether to refer the individual either directly or via an NHS clinical genomics service or other relevant clinical speciality for genomic testing following clinical review of their and their family’s medical history if known, and the relevant genomic testing eligibility criteria.

The 17 NHS Clinical Genomic Services (NHS CGSs), commissioned by NHS England, deliver a comprehensive clinical genomic and counselling service that directs the diagnosis, risk assessment and lifelong clinical management of patients of all ages and their families who have, or are at risk of having, a rare genetic or genomic condition. As part of the NHS CGS, the patient and their family will access diagnosis, and management relevant to their particular condition, but also receive support and guidance so that they are able to understand their condition, its implications, and their options in relation to reproduction, screening, prevention and clinical management.


Written Question
Marine Protected Areas: Fishing Vessels
Wednesday 27th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if he will make it his policy to prohibit the use of bottom-towed fishing gear in Marine Protected Areas.

Answered by Mark Spencer

I refer the hon. Member to the answer I gave to the hon. Member for North Devon, on 22 January 2024, PQ UIN 9706.

A byelaw restricting the use of bottom-towed fishing gear in 13 Marine Protected Areas mentioned in that answer came into force on 22 March 2024.


Written Question
Airports
Thursday 21st March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department for Transport:

To ask the Secretary of State for Transport, whether the review of slots policy will clarify the exemption for non-use of slots for reasons outside the control of the carrier.

Answered by Anthony Browne

We published the airport slot reform consultation on 4 December 2023 putting forward options for longer term reform of the slot system, including powers to provide alleviation from slot rules in exceptional circumstances. The consultation closed on 8 March. We are considering responses and will set out next steps in due course.

In addition, a permanent expansion of justified non-utilisation provisions to include pandemics and other health crisis is being taken forward separately using powers in the Retained EU Law (Revocation and Reform) Act 2023.


Written Question
Animal Welfare
Tuesday 19th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, when he plans to publish the findings of the post-implementation review of the Animal Welfare (Licensing of Activities Involving Animals) (England) Regulations 2018.

Answered by Mark Spencer

Defra has undertaken a post-implementation review (PIR) of the Animal Welfare (Licensing of Activities Involving Animals) (England) Regulations 2018 (the 2018 Regulations) as mandated by the regulations’ review clause. This evaluation assesses the extent to which the regulations have achieved their intended goals and identifies areas for potential improvement.

The PIR will be published soon.


Written Question
Animal Experiments: Animal Welfare
Monday 18th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Home Office:

To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits of introducing a fee for a project licence under the Animals (Scientific Procedures) Act 1986 and using the funds generated to (a) support the further development of non-animal methods and (b) improve enforcement of the regulatory framework.

Answered by Tom Tugendhat - Shadow Minister (Home Office) (Security)

The Government charges fees for regulation under the Animals (Scientific Procedures) Act 1986 on a full cost recovery basis. The Government has no plans to introduce a fee for project licences. The Government will shortly increase the current fees to maintain high standards of regulation.

The Government recently announced that it will double investment, from £10m to £20m per annum, in research to achieve the three Rs (replacement, reduction and refinement) and develop non-animal alternatives. The Government will also publish a plan to accelerate the development, validation and uptake of technologies and methods to reduce reliance on the use of animals in science.


Written Question
Personal Savings
Monday 18th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps his Department is taking to help people save for the future.

Answered by Paul Maynard

Retirement saving has been transformed with over 11 million employees put into workplace pensions since 2012.

We are committed to the expansion of Automatic Enrolment in the mid-2020s. Our reforms will benefit younger workers and increase overall amounts being saved, with 3m people saving £2bn extra a year.


Written Question
Undocumented Migrants
Tuesday 12th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, what diplomatic steps his Department is taking to help tackle illegal migration.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

We [FCDO] are engaging with international partners on a 'whole of route' approach to addressing irregular migration. This includes a multi-year operational plan with France to stop small boats, developing partnerships to tackle organised immigration crime, improving returns processes and working with partner countries through international fora to address the root causes of irregular migration, such as conflict and climate change.


Written Question
Cardiovascular Diseases: Research
Monday 4th March 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage research into cardiovascular disease (a) treatment and (b) prevention.

Answered by Andrew Stephenson

The Department funds research into the treatment and prevention of cardiovascular disease through the National Institute for Health and Care Research (NIHR). In January 2023, the Department updated its areas of research interest (ARIs), which highlight to the patient, academic, clinical and life sciences community the areas where we want to expand our efforts and work together to systematically understand, intervene and improve public, patient, and service outcomes. ARI1 focuses on prevention, early diagnosis and appropriate intervention for people at increased risk of poor health, including cardiovascular disease. Supporting ARI1, the three NIHR Research Schools were awarded £10 million to deliver a collaborative programme of prevention research between 2023 and 2027. The programme will have a strong emphasis on capacity building. It will also encourage practitioners to participate in prevention research as a step towards establishing their own longer-term research careers and help address gaps between research and practice.


Written Question
Animal Welfare: Import Controls
Tuesday 27th February 2024

Asked by: Henry Smith (Conservative - Crawley)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if he will bring forward legislative proposals to ensure that the UK requires imports of (a) meat, (b) milk, (c) eggs and (d) fish to meet UK animal welfare standards.

Answered by Mark Spencer

The Government is proud of the high food standards that underpin our high-quality Great British produce. We will never compromise on these.

All agri-food products, including those from countries we have trade agreements with, must comply with our import requirements in order to be placed on the UK market. This includes ensuring imported meat products have been slaughtered to animal welfare standards equivalent to our domestic standards.

The Government will use our expertise and influence to drive enhanced animal welfare and food safety standards globally.